Literature DB >> 24005144

Probiotics: immunomodulatory properties in allergy and eczema.

L Drago1, M Toscano, P D Pigatto.   

Abstract

In the last decades the prevalence of allergic diseases and eczema raised significantly, and today they are the most common chronic pathologies affecting children. It has been shown that a functional intestinal mucosa provides a defensive barrier to the host against potential dangerous antigens, regulating the tolerance to them. Some inflammatory diseases of the gut weaken the barrier causing an increase in the mucosa permeability and in antigenic transition. As a consequence, there is an aberrant immune response and the release of pro-inflammatory cytokines further compromises the barrier functionality. It has been demonstrated that a correlation between allergy and eczema onset and the intestinal microflora composition exists, and in particular, it has been showed that some microorganisms are able to influence the immune response. For these reasons it has been hypothesized that probiotics may have a beneficial role in preventing and treating allergies and eczema. However, the benefits of this treatment depend on many factors, such as the bacterial strain, the duration of administration, the pathology, the patient characteristics (age, diet, allergy predisposition). The aim of this work was to review the present knowledge about the use of probiotics in allergic diseases and eczema, highlighting their role in the aforementioned pathologies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24005144

Source DB:  PubMed          Journal:  G Ital Dermatol Venereol        ISSN: 0392-0488            Impact factor:   2.011


  4 in total

1.  Immunomodulatory Effects of Lactobacillus salivarius LS01 and Bifidobacterium breve BR03, Alone and in Combination, on Peripheral Blood Mononuclear Cells of Allergic Asthmatics.

Authors:  Lorenzo Drago; Elena De Vecchi; Arianna Gabrieli; Roberta De Grandi; Marco Toscano
Journal:  Allergy Asthma Immunol Res       Date:  2015-03-05       Impact factor: 5.764

2.  Effect of Lactobacillus rhamnosus HN001 and Bifidobacterium longum BB536 on the healthy gut microbiota composition at phyla and species level: A preliminary study.

Authors:  Marco Toscano; Roberta De Grandi; Laura Stronati; Elena De Vecchi; Lorenzo Drago
Journal:  World J Gastroenterol       Date:  2017-04-21       Impact factor: 5.742

3.  Study effect of probiotics and prebiotics on treatment of OVA-LPS-induced of allergic asthma inflammation and pneumonia by regulating the TLR4/NF-kB signaling pathway.

Authors:  Zhiwei Wu; Entezar Mehrabi Nasab; Poonam Arora; Seyyed Shamsadin Athari
Journal:  J Transl Med       Date:  2022-03-16       Impact factor: 5.531

4.  Skin microbiota of first cousins affected by psoriasis and atopic dermatitis.

Authors:  Lorenzo Drago; Roberta De Grandi; Gianfranco Altomare; Paolo Pigatto; Oliviero Rossi; Marco Toscano
Journal:  Clin Mol Allergy       Date:  2016-01-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.